{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T01:59:19Z","timestamp":1773367159754,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":293,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.curtheres.2025.100813","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T21:39:19Z","timestamp":1761341959000},"page":"100813","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The Effects of Fasinumab on Peripheral Nerve Function and Ganglion Anatomy: Results From a Randomized, Double-Blind, Placebo-Controlled Study in Patients With Pain Due to Osteoarthritis of the Knee or Hip, and a Series of Nonclinical Studies"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4964-5729","authenticated-orcid":false,"given":"Simon","family":"Eng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fetell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haitao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingning","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesus","family":"Trejos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz","family":"Cortes-Burgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garen","family":"Manvelian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yamini","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngan","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth C.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazem E.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"DiMartino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory P.","family":"Geba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ned","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn E.","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy","family":"Soltys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan D.","family":"Croll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Dakin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.curtheres.2025.100813_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2005.01.013","article-title":"Osteoarthritis: an overview of the disease and its treatment strategies","volume":"35","author":"Sarzi-Puttini","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 120","key":"10.1016\/j.curtheres.2025.100813_bib0002","first-page":"3","article-title":"Osteoarthritis is a serious disease","volume":"37","author":"Hawker","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.curtheres.2025.100813_bib0003","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S0140-6736(17)31744-0","article-title":"Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis","volume":"390","author":"da Costa","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.curtheres.2025.100813_bib0004","doi-asserted-by":"crossref","first-page":"n2321","DOI":"10.1136\/bmj.n2321","article-title":"Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: a network meta-analysis","volume":"375","author":"da Costa","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.curtheres.2025.100813_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/CS20050163","article-title":"Neurotrophin signalling in health and disease","volume":"110","author":"Chao","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.curtheres.2025.100813_bib0006","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0092-8674(94)90378-6","article-title":"Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons","volume":"76","author":"Crowley","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.curtheres.2025.100813_bib0007","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/368246a0","article-title":"Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk\/NGF receptor gene","volume":"368","author":"Smeyne","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.curtheres.2025.100813_bib0008","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev.neuro.29.051605.112929","article-title":"Neurotrophins: mediators and modulators of pain","volume":"29","author":"Pezet","year":"2006","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.curtheres.2025.100813_bib0009","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/j.1460-9568.1994.tb00581.x","article-title":"Peripheral and central mechanisms of NGF-induced hyperalgesia","volume":"6","author":"Lewin","year":"1994","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.curtheres.2025.100813_bib0010","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1212\/WNL.54.5.1080","article-title":"A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS clinical trials group team 291","volume":"54","author":"McArthur","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.curtheres.2025.100813_bib0011","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1046\/j.1460-9568.1999.00491.x","article-title":"Adrenergic innervation of rat sensory ganglia following proximal or distal painful sciatic neuropathy: distinct mechanisms revealed by anti-NGF treatment","volume":"11","author":"Ramer","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.curtheres.2025.100813_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1179209","article-title":"Confronting the loss of trophic support","volume":"16","author":"Hu","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.curtheres.2025.100813_bib0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(79)90871-0","article-title":"Immunization of adult rats against 2.5 S NGF: effects on the peripheral sympathetic nervous system","volume":"176","author":"Otten","year":"1979","journal-title":"Brain Res"},{"key":"10.1016\/j.curtheres.2025.100813_bib0014","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1523\/JNEUROSCI.10-07-02412.1990","article-title":"Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse","volume":"10","author":"Ruit","year":"1990","journal-title":"J Neurosci"},{"key":"10.1016\/j.curtheres.2025.100813_bib0015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1523\/JNEUROSCI.21-02-00363.2001","article-title":"Nerve growth factor antiserum induces axotomy-like changes in neuropeptide expression in intact sympathetic and sensory neurons","volume":"21","author":"Shadiack","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.curtheres.2025.100813_bib0016","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41584-020-00528-4","article-title":"The evolution of nerve growth factor inhibition in clinical medicine","volume":"17","author":"Wise","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.curtheres.2025.100813_bib0017","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.pain.2014.03.018","article-title":"Fasinumab (REGN475), an antibody against nerve growth factor for the treatment of pain: Results from a double-blind, placebo-controlled exploratory study in osteoarthritis of the knee","volume":"155","author":"Tiseo","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.curtheres.2025.100813_bib0018","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/art.41012","article-title":"The efficacy, tolerability, and joint safety of fasinumab in osteoarthritis pain: A phase IIb\/III double-blind, placebo-controlled, randomized clinical trial","volume":"71","author":"Dakin","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.curtheres.2025.100813_bib0019","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12891-025-08402-8","article-title":"Efficacy and safety of fasinumab in an NSAID-controlled study in patients with pain due to osteoarthritis of the knee or hip","volume":"26","author":"DiMartino","year":"2025","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.curtheres.2025.100813_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ocarto.2024.100533","article-title":"A phase III study to evaluate the long-term safety and efficacy of fasinumab in patients with pain due to osteoarthritis of the knee or hip","volume":"6","author":"DiMartino","year":"2024","journal-title":"Osteoarthr Cartil Open"},{"key":"10.1016\/j.curtheres.2025.100813_bib0021","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/1529-0131(200108)45:4<384::AID-ART352>3.0.CO;2-0","volume":"45","author":"Angst","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.curtheres.2025.100813_bib0022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2377-8-33","article-title":"Efficacy and safety of pregabalin 600 mg\/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial","volume":"8","author":"Arezzo","year":"2008","journal-title":"BMC Neurol"},{"key":"10.1016\/j.curtheres.2025.100813_bib0023","unstructured":"Albers J. Nerve conduction manual, University of Michigan Hospital. Available at: https:\/\/www.scribd.com\/document\/804946792\/Nerve-Conduction-Manual-PDFDrive. [Accessed January 16, 2025]."},{"key":"10.1016\/j.curtheres.2025.100813_bib0024","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.joca.2024.07.001","article-title":"Prevalence of preexisting articular bone pathology in patients with osteoarthritis screened for fasinumab clinical trials identified by X-ray or magnetic resonance imaging","volume":"32","author":"DiMartino","year":"2024","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.curtheres.2025.100813_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120184","article-title":"Neurological safety of subcutaneous tanezumab versus NSAID in patients with osteoarthritis","volume":"434","author":"Brown","year":"2022","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.curtheres.2025.100813_bib0026","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/art.39943","article-title":"Long-term safety and efficacy of fulranumab in patients with moderate-to-severe osteoarthritis pain: a phase II randomized, double-blind, placebo-controlled extension study","volume":"69","author":"Sanga","year":"2017","journal-title":"Arthritis Rheumatol"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X25000384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X25000384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:52:53Z","timestamp":1773323573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X25000384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":26,"alternative-id":["S0011393X25000384"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2025.100813","relation":{},"ISSN":["0011-393X"],"issn-type":[{"value":"0011-393X","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effects of Fasinumab on Peripheral Nerve Function and Ganglion Anatomy: Results From a Randomized, Double-Blind, Placebo-Controlled Study in Patients With Pain Due to Osteoarthritis of the Knee or Hip, and a Series of Nonclinical Studies","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2025.100813","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100813"}}